Menu Search
Equities

Ramsay Generale de Sante SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GD6:DUS

Ramsay Generale de Sante SA

Actions
  • Price (EUR)10.70
  • Today's Change0.05 / 0.47%
  • Shares traded--
  • 1 Year change+13.59%
  • Beta0.0551
Data delayed at least 15 minutes, as of Feb 13 2026 15:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ramsay Generale de Sante SA, formerly Generale de Sante SA (GDS), is a France-based company engaged in the provision of private hospital healthcare services. The Company offers a range of hospital services and, in partnership with independent medical specialists, delivers a spectrum of care services, including oncology and radiation therapy; care for alcohol abuse and obesity; rehabilitation, such as cardiac rehabilitation and orthopedic and neurological reeducation, and diagnostics, such as medical imaging and analysis. In addition, the Company develops a care package, offering care with personal support, before, during and after hospitalization. The Company operates approximately 75 centers and institutions in France. The Company operates through a number of subsidiaries, such as HPM Hopital Prive Metropole SAS. Ramsay Health Care (UK) Ltd is the major shareholder of the Company.

  • Revenue in EUR (TTM)5.24bn
  • Net income in EUR-54.10m
  • Incorporated1991
  • Employees40.00k
  • Location
    Ramsay Generale de Sante SA39 Rue Mstislav RostropovitchPARIS 75017FranceFRA
  • Phone+33 231433143
  • Fax+33 147236366
  • Websitehttps://www.ramsaysante.fr/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.